United Therapeutics' Tyvaso meets primary endpoint in IPF study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. MSFT

Go back to United Therapeutics' Tyvaso meets primary endpoint in IPF study
United Therapeutics Corp (NASDAQ: UTHR) Delayed: 538.96 +2.37 (0.44%)
Previous Close $536.59    52 Week High $164.04 
Open $541.25    52 Week Low $97.52 
Day High $541.53    P/E 98.53 
Day Low $533.49    EPS $5.47 
Volume 301,687